Sept 2 (Reuters) - CSPC Pharmaceutical Group Ltd :
* NBL-015 OBTAINS CLINICAL TRIAL APPROVAL BY NMPA OF PRC
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Sept 2 (Reuters) - CSPC Pharmaceutical Group Ltd :
* NBL-015 OBTAINS CLINICAL TRIAL APPROVAL BY NMPA OF PRC
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论